Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-08
2006-08-08
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S167000, C546S159000, C514S311000, C514S314000
Reexamination Certificate
active
07087758
ABSTRACT:
This invention relates to novel quinoline inhibitors of hYAK1 and hYAK3 kinases and pharmaceutically acceptable salts, hydrates or solvates thereof, pharmaceutical compositions thereof, and methods of treatment of diseases in which an excessive amount of either such kinase is a factor.
REFERENCES:
patent: 5112837 (1992-05-01), Burrows et al.
patent: 5908930 (1999-06-01), Dow
patent: 6225329 (2001-05-01), Richter et al.
patent: 6342514 (2002-01-01), Petrie et al.
patent: 96/28444 (1996-09-01), None
patent: WO 00/42026 (2000-07-01), None
Bryan Deborah L.
Burgess Joelle L.
Callahan James F.
Coulter Kathryn L.
Seaman D. Margaret
SmithKline Beecham Corporation
LandOfFree
Quinoline inhibitors of hyaki and hyak3 kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline inhibitors of hyaki and hyak3 kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline inhibitors of hyaki and hyak3 kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3713524